Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Dec 22, 2025
Reporting period
Not applicable
Filed with the SEC
Dec 23, 2025
DirectorIndirect holdingOther
Context
Classification
other
Code P in the derivative table; not an open-market share purchase
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001878313-25-000073
Filed / recorded
Dec 23, 2025, 6:18 PM UTC
Added to OQRO
Oct 8, 2026, 2:06 AM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
MAIA Biotechnology, Inc.
Issuer CIK
1878313
Ticker
MAIA
Reporting person
Stan Smith
Relationship
Director
Security
Stock Options
Table
Derivative (Table II)
Transaction date
Dec 22, 2025
Transaction code
P
Shares / units
57,189
Price per share
$1.36
Acquired / disposed
Acquired (A)
Shares owned after
57,189
Ownership form
Indirect — See footnote
Amendment
No
Footnotes from the filing
These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on December 22, 2025. The options are exercisable beginning on the sixth month anniversary of the issuance date and expire 3-years after the initial issuance date.
These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.